Michael Egholm - 08 Apr 2024 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role: President & CEO, Director
Signature: /s/ Michael Egholm by Agnieszka Gallagher, Attorney-in-Fact
Issuer symbol: LAB
Transactions as of: 08 Apr 2024
Net transactions value: -$277,948
Form type: 4
Filing time: 09 Apr 2024, 19:11:29 UTC
Previous filing: 05 Apr 2024
Next filing: 21 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LAB	Common Stock	Tax liability	$277,948	-102,564	-16%	$2.71	531,592	08 Apr 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain performance-based restricted stock units ("RSUs") granted to the reporting person on April 11, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on April 5, 2024 upon the determination by the Board of Directors of the Issuer that certain of the performance-based conditions were met.

Content

The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain performance-based restricted stock units ("RSUs") granted to the reporting person on April 11, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on April 5, 2024 upon the determination by the Board of Directors of the Issuer that certain of the performance-based conditions were met.